Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist-Reference-Cited by-同舟云学术

Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist

Published:2014-06 Issue:12 Volume:24 Page:2744-2748
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Dasgupta Bireshwar,Kozlowski Edward,Schroeder Daniel R.,Torrente John R.,Xu Cen,Pin Sokhom,Conway Charlie M.,Dubowchik Gene M.,Macor John E.,Vrudhula Vivekananda M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Migraine — Current Understanding and Treatment

2. MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATE

3. Aspects on the Pathophysiology of Migraine and Cluster Headache

4. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect

5. Origin of pain in migraine: evidence for peripheral sensitisation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Based Drug Discovery of N-((R)-3-(7-Methyl-1H-indazol-5-yl)-1-oxo-1-(((S)-1-oxo-3-(piperidin-4-yl)-1-(4-(pyridin-4-yl)piperazin-1-yl)propan-2-yl)amino)propan-2-yl)-2′-oxo-1′,2′-dihydrospiro[piperidine-4,4′-pyrido[2,3-d][1,3]oxazine]-1-carboxamide (HTL22562): A Calcitonin Gene-Related Peptide Receptor Antagonist for Acute Treatment of Migraine;Journal of Medicinal Chemistry;2020-06-19

2. An efficient synthesis of the piperidinyl dihydroquinazolinone (PDQ) fragment of olcegepant;Tetrahedron Letters;2018-09

3. Diversity-Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides;Chemistry - A European Journal;2017-09-12